RA Outcomes Improved in KURAMA Cohort - Top-Institutions - MDSpire

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.

  • By

  • Andrea Surnit

  • May 22, 2026

  • 4 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine
    Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine

    Kyoto, Kyoto

    Key Differentiators

    • Rheumatology

  • #2

    Nagoya University Hospital
    Nagoya University Hospital

    Nagoya, Aichi

    Key Differentiators

    • Rheumatology

  • #3

    Aarhus University Hospital
    Aarhus University Hospital

    Aarhus, Central Jutland

    Key Differentiators

    • Rheumatology

  • #4

    Aalborg University Hospital Farsø
    Aalborg University Hospital Farsø

    Aalborg, North Denmark

    Key Differentiators

    • Rheumatology

  • #5

    Copenhagen University Hospital Herlev-Gentofte
    Copenhagen University Hospital Herlev-Gentofte

    Copenhagen, Capital Region

    Key Differentiators

    • Rheumatology

Original Source(s)

RA Outcomes Improved in KURAMA Cohort

  • by Andrea Surnit

  • May 22, 2026

Related Content

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.

Sex Differences Seen in Immune Cells

Single-cell analysis identified sex-biased immune-cell composition, gene expression, and genetic regulation in unstimulated blood immune cells